This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Cancer registry: Topography ICD-O-3
ANY
Cancer registry: Morphology ICD-O-3
9840|9861|986[67]|987[1-4]|989[1567]|9910|9920|993[01]
Cancer registry: Behaviour codes
3
1 out of 7 registries used, show all original rules.
276
Check minimum number of events None
276
Include endpoints None
276
Remove individuals based on genotype QC
244
HLP_C3_AML
Control definitions
Control exclude
C3_CANCER, C3_CANCER_WIDE
Extra metadata
First used in FinnGen datafreeze
DF8
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Acute myeloid leukaemia
based on the number of shared cases.
Broader endpoints:
- Acute myeloid leukaemia
- Acute myeloid leukaemia (controls excluding all cancers)
- Any event in cancer register
- Neoplasms
- Any event in hilmo or specialist outpatient
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 244 | 94 | 150 |
| Unadjusted prevalence (%) | 0.06 | 0.04 | 0.08 |
| Mean age at first event (years) | 61.61 | 54.48 | 66.08 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: HLP_C3_AML – Acute myeloid leukaemia
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Acute myeloid leukaemia
↥Endpoint not on priority list, no data to show.